
Home - IAVI
IAVI's mission is to translate scientific discoveries into affordable, globally accessible public health solutions, ensuring access for all.
About IAVI
IAVI is a nonprofit scientific research organization. We develop vaccines and antibodies for HIV, tuberculosis, and emerging diseases.
HIV Vaccines - IAVI
An HIV vaccine is still needed to bring a true end to the HIV pandemic. IAVI has led the search for an HIV vaccine since 1996.
Careers - IAVI
At IAVI we work to foster an environment and culture where people enjoy working, feel engaged, can be their true selves, and can thrive. Join IAVI, where you can be your best professional self and feel like …
Senior Leadership - IAVI
Jon Heinrichs leads IAVI’s discovery science efforts. In this role, he oversees activities at IAVI’s research laboratories in Brooklyn, NY; La Jolla, CA; and Faridibad, India, working with the teams to …
- [PDF]
About IAVI
IAVI is a nonprofit organization dedicated to developing vaccines and antibodies for HIV, tuberculosis, emerging infectious diseases, and neglected diseases. Our mission is to translate scientific …
Two HIV vaccine trials show proof of concept for pathway to ... - iavi.org
May 15, 2025 · IAVI is a non-profit scientific research organization dedicated to addressing global, unmet health challenges including HIV, tuberculosis and a range of emerging infectious diseases.
Our Story - IAVI
The International AIDS Vaccine Initiative (IAVI) was conceived at the meeting as a vehicle to address these issues. Launched in 1996 as a nonprofit, public-private, product development partnership …
Pipeline - IAVI
For information on programs where IAVI is a key partner, visit our pipeline of IAVI-supported candidates. For an explanation of development phases, visit our clinical development page.
Don’t Stop Believin’: This year’s HIV vaccine research theme - IAVI
Mar 14, 2024 · A full set of results, including both the immunogenicity data and information about skin reactions among some vaccinees that were discussed recently in Science and a statement from …